Does vitamin E decrease heart attack risk? Summary and implications with respect to dietary recommendations

Journal of Nutrition

Volumn 131, Issue 2, 2001, Pages

  Traber, Maret G ^a,b,c  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of Illinois School of Medicine   (United States)

Author keywords

Adhesion molecule; Atherosclerosis; Cytokine; Nitric oxide; Platelet aggregation; Superoxide; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; CELL ADHESION MOLECULE; CYTOKINE; NITRIC OXIDE; PROTEIN KINASE C; SUPEROXIDE;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CONFERENCE PAPER; CORONARY RISK; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION PREVENTION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 0035147024     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/131.2.395s     Document Type: Conference Paper

References (39)

1. Inhibition of cell proliferation by α-tocopherol. Role of protein kinase C
2. α-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation
3. Decreased prostacyclin synthesis in vitamin E-deficient rabbit aorta
4. 2 in megakaryocytes
5. 2, arachidonic acid release and cyclooxygenasein endothelial cells
6. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols
7. The effect of α-tocopherol on the synthesis, phosphorylation and activity of protein kinase C in smooth muscle cells after phorbol12-myristate 13-acetate down-regulation
8. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells
9. Dose-response comparison of RRR-α-tocopherol and all-racemic α-tocopherol on LDL oxidation
10. α-tocopherol decreases interleukin-1β release from activated human monocytes by inhibition of 5-lipoxygenase
11. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium
12. α-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells
13. α-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism
14. RRR-α-Tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus
15. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSl-Prevenzione trial
16. Effects of vitamin E on the aggregation and the lipid peroxidation of platelets exposed to hydrogen peroxide
17. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism
18. α-tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells
19. The effect of α-tocopherol supplementation on LDL oxidation. A dose-response study
20. Vitamin E and vascular homeostasis: Implications for atherosclerosis
21. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro
22. Peroxidative stress and in vitro ageing of endothelial cells increases the monocyte-endothelial cell adherence in a human in vitro system
23. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice
24. Vitamin E consumption and the risk of coronary heart disease in men
25. Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation: Modulation by oxidation and vitamin E
26. Vitamin E consumption and risk of coronary disease in women
27. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and d-α-tocopherol in vascular smooth muscle cells
28. Oxidative modification of LDL and atherogenesis. The 1995 Lewis A. Conner Memorial Lecture
29. Vitamin E. An inhibitor of the platelet release reaction
30. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
31. Dietary supplementation with vitamin E in hyperlipoproteinemias: Effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability
32. d-α-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties
33. Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E
34. Chronic exposure of cultured bovine endothelial cells to oxidized LDL abolishes prostacyclin release
35. R,R,R-α-Tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for structural specificity of the tocopherol molecule
36. 2 activity in rat heart myoblastic cells
37. Tocopherol-mediated peroxidation of lipoproteins: Implications for vitamin E as a potential anti-atherogenic supplement
38. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study investigators